Key facts
- It has raised $540K; the latest was Seed Round ($540K) in Feb 2026.
- Notable investors include Hong Kong BlueSky Technologies Innovation, Yamashina Seiki.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Endoluminal Solutions
- ·The full record, as it builds
Funding rounds
No funding rounds for Endoluminal Solutions are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endoluminal Solutions
Developer of the world's first disposable endoscope specifically designed for gastric cancer screening. The company offers a 4mm ultra-thin, fully disposable gastroscope that eliminates infection risks and the need for sterilization, enabling medical facilities to conduct large-scale, efficient, and pain-free screenings with enhanced precision through AI diagnostic support.
- Sector
- Healthcare
- HQ
- Osaka, Japan
- Founded
- 2025
- Website
- endoluminalsolutions.com/
- Ownership
- Privately Held (backing)
Endoluminal Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endoluminal Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endoluminal Solutions in its N-PORT filings yet. We sweep new filings monthly.